ZOLPIDEM TARTRATE

Post-LOE

zolpidem tartrate sublingual

Pfizer

ANDASUBLINGUALTABLET

Approved

Sep 2017

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

2/8 — Basic

Drug data last refreshed 20h ago

Mechanism of Action

Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Clinical Trials (3)

NCT00283790Phase 4Completed

Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo

Started Jan 2006

36 enrolled

Insomnia

NCT00833937Phase 1Completed

Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions

Started Mar 2002

24 enrolled

Healthy

NCT00833521Phase 1Completed

Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions

Started Feb 2002

38 enrolled

Healthy

Company

Worked on ZOLPIDEM TARTRATE at Pfizer? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.